NCT02135471

Brief Summary

Smoking has a negative effect on the predictability and stability of root coverage procedures because of decreased blood supply and fibroblast activity. Long-term evaluation of this procedure in smokers is important for clinical decision making, because it provides information about the stability of results over time. In smokers, enamel matrix derivative (EMD) used at acellular dermal matrix graft (ADMG)/ soft tissue interface could be an alternative to improve the deficient healing potential, since EMD has the capability of stimulating angiogenesis. At the ADMG/ root surface interface, it could improve the deficient fibroblast activity in smokers and therefore reduce the presence of a long junctional epithelium. The aim of this randomised controlled clinical study was to investigate whether EMD contributes to the root coverage of gingival recessions performed with ADMG in smokers during a 12-month follow-up. Twenty smokers with bilateral Miller Class I or II gingival recessions ≥ 3 mm will be selected. The test group will be treated with an association of ADMG and EMD, and the control group with ADMG alone. Some clinical parameters as: probing depth, relative clinical attachment level, gingival recession height, gingival recession width, keratinized tissue width and keratinized tissue thickness will be evaluated before surgery and after twelve months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Jun 2009

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 5, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 12, 2014

Completed
Last Updated

May 12, 2014

Status Verified

May 1, 2014

Enrollment Period

2.4 years

First QC Date

May 5, 2014

Last Update Submit

May 9, 2014

Conditions

Keywords

gingival recessiondental enamel proteinsacellular dermal matrix grafttobacco

Outcome Measures

Primary Outcomes (1)

  • Percentage of root coverage

    twelve months

Secondary Outcomes (7)

  • Probing depth

    twelve months

  • relative clinical attachment level

    Twelve months

  • gingival recession height

    Twelve months

  • gingival recession width

    twelve months

  • keratinized tissue width

    twelve months

  • +2 more secondary outcomes

Study Arms (2)

acellular dermal matrix graft

EXPERIMENTAL
Drug: acellular dermal matrix graft

enamel matrix derivative

EXPERIMENTAL
Drug: acellular dermal matrix graftDrug: enamel matrix derivative

Interventions

On one side, the previously reflected partial-thickness flaps will be coronally positioned to entirely cover the acellular dermal matrix graft (ADMG), and also sutured with sling sutures using 6-0 bioabsorbable sutures.

Also known as: Alloderm
acellular dermal matrix graftenamel matrix derivative

On the other side, the same procedure will be performed, with an additional layer of enamel matrix derivative between the acellular dermal matrix graft (ADMG) and the flap, and between the ADMG and the root surface by using a sterile brush.

Also known as: Emdogain
enamel matrix derivative

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • smokers (consuming 10 or more cigarettes/ day, for over five years)
  • The subjects should have bilateral large, Miller (1985) Class I or II, ≥ 3 mm maxillary or mandibular gingival recession in non-molar teeth of different quadrants and in the same dental arch.

You may not qualify if:

  • any systemic condition
  • daily drug intake
  • periodontal pockets associated with the gingival recessions or adjacent teeth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Oral Surgery and Periodontology - Ribeirão Preto School of Dentistry, University of São Paulo

Ribeirão Preto, São Paulo, 14040-904, Brazil

Location

Related Publications (1)

  • Alves LB, Costa PP, Scombatti de Souza SL, de Moraes Grisi MF, Palioto DB, Taba M Jr, Novaes AB Jr. Acellular dermal matrix graft with or without enamel matrix derivative for root coverage in smokers: a randomized clinical study. J Clin Periodontol. 2012 Apr;39(4):393-9. doi: 10.1111/j.1600-051X.2012.01851.x. Epub 2012 Feb 5.

    PMID: 22409423BACKGROUND

MeSH Terms

Conditions

Gingival Recession

Interventions

Allodermenamel matrix proteins

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Study Officials

  • Arthur B Novaes, Professor

    Department of Oral Surgery and Periodontology - Ribeirão Preto School of Dentistry, University of São Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Titular Professor of Department of Oral Surgery and Periodontology

Study Record Dates

First Submitted

May 5, 2014

First Posted

May 12, 2014

Study Start

June 1, 2009

Primary Completion

November 1, 2011

Study Completion

November 1, 2012

Last Updated

May 12, 2014

Record last verified: 2014-05

Locations